FDA approves new drug treatment for nausea and vomiting from chemotherapy
FDA approves new drug treatment for nausea and vomiting from chemotherapy
FDA approves new drug treatment for nausea and vomiting from chemotherapy 09/02/2015 09:38 AM EDT The U.S. Food and Drug Administration approved September 2, 2015 Release The U.S. Food and Drug Administration approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting (emesis). Varubi is approved in adults in combination with other drugs (antiemetic agents)…
View On WordPress








